Markets | | Discounters Win In The Rush To Pantry-Load
It’s no secret the pandemic spurred a round of pantry-hoarding the likes of which we’ve never before seen. Staples giant and dividend powerhouse Clorox (CLX) said demand increases for some of its products topped 500% and that is no joke. 500%. ... Read the Full Story |
|
From Our Partners | | Each morning, the Wave Software scans the market for stocks quietly building momentum over days or weeks, then narrows the list to a single name showing signs of an imminent move.
From there, it outlines specific options criteria designed to match that potential move, giving traders a complete setup before the market opens.
No guesswork, no scanning countless charts, just one focused opportunity to evaluate each day. | | See how the Wave Software pinpoints daily trade opportunities before 9 am. |
|
Markets | |
With restaurant dining rooms only just starting to come back in a lot of places—some have been open for most of a month in at least some capacity—one thing was clear: when the going gets tough, America gets take-out. And take-out pizza was a very big deal in the last month, as reported... Read the Full Story |
|
Markets | | Shares of the enigmatic athleisure brand Under Armour (NYSE: UAA) (NYSE: UA) have been in a downtrend since peaking in July 2019 at $27.72 on the heels of its last upbeat earnings report. Management ate crow in the following quarters as they missed guidance and continued to lose credibility with shr... Read the Full Story |
|
From Our Partners | | 232 companies listed on U.S. exchanges this year, raising over $251 billion by late July alone - more than five times 2025's full-year total. Yet most carry almost no analyst coverage.
We screened the entire class for average daily volume above 500,000 shares, market caps over $100 million, and at least 18 months of cash runway. Only seven names cleared every filter - four already trading, three still private. | | See the seven IPOs that passed every filter. |
|
Markets | | It’s Not Consensus That Matters
Autozone (AZO) made headlines this morning after it reported consensus-beating results for the calendar 1st quarter. While a consensus beat is a great thing, it does not make a stock a buy, especially if the outlook for future growth is in peril. In the case of... Read the Full Story |
|
Markets | | Fantasy sports betting platform Draft Kings (NASDAQ: DKNG) shares have accelerated as a pandemic beneficiary play. The absence of live sports events has caused fans to embark upon fantasy sports to meet their fix with the potential to win cash and prizes. Stay-in-shelter isolation mandates generated... Read the Full Story |
|
From Our Partners | | Unitree's IPO grabbed headlines, but a handful of already-public robotics companies have been quietly delivering results that look nothing like hype.
One robotics-and-testing firm grew quarterly revenue from $686 million to $1.282 billion year over year and broke out above a $422.11 buy point. A warehouse robotics company exited the quarter with a $22.7 billion backlog and $2.0 billion in cash with no debt. A robotic surgery leader placed 431 systems in a single quarter. | | Get the free robotics stock report now. |
|
Markets | |
Technology moves at a mile a minute these days. This is particularly true in the business world, which is rapidly evolving as a result of new and innovative companies that help companies handle their operations in better and more efficient ways. Look no further than some of the fintech companies t... Read the Full Story |
|
Markets | | Target Reports Results And Blows Past The Consensus
Target (TGT) reported earnings this morning and led me to a singular conclusion; tech is going to boom this year. I’m sure by now you’re thinking that I’m either crazy, Target is doing something behind the scenes you don’t ... Read the Full Story |
|
Markets | |
Have you been aching for a lunch of soup, salad and breadsticks at your local Olive Garden? If that's the case, then you're in luck; Darden Restaurants (NYSE: DRI) has a plan to open up almost two out of every three of its dining rooms by the end of the month, and it's not just Olive Garden, eithe... Read the Full Story |
|
Markets | | There’s A Lot Of Good News Out There
The stock market is often an irrational beast and never more so, seemingly than when it is discounting a future event. Take, for instance, the recent correction. The correction was sharp and swift, not because the economy was in decline but because of an e... Read the Full Story |
|
Markets | | Fertility benefits management company Progyny, Inc. (NASDAQ: PGNY) fills a void in health insurance coverage that the world’s leading companies embrace to attract and keep top talent. Infertility coverage that is not deemed ‘medically necessary’ is not covered by most health plans... Read the Full Story |
|
The Early Bird Stock Of The Day Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. Its lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. The company is also developing ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma for treating other CD70+ solid tumor and hematological malignancies indications. The company was founded in 2014 and is based in Boston, Massachusetts. | | View Today's Stock Pick |
|
